Biochemical characterization of SARS-CoV-2 nucleocapsid protein
- PMID: 32416961
- PMCID: PMC7190499
- DOI: 10.1016/j.bbrc.2020.04.136
Biochemical characterization of SARS-CoV-2 nucleocapsid protein
Erratum in
-
Corrigendum to "Biochemical characterization of SARS-CoV-2 nucleocapsid protein".Biochem Biophys Res Commun. 2022 Jul 23;614:225. doi: 10.1016/j.bbrc.2022.05.058. Epub 2022 May 25. Biochem Biophys Res Commun. 2022. PMID: 35643631 Free PMC article. No abstract available.
Abstract
The nucleocapsid (N) protein is an important antigen for coronavirus, which participate in RNA package and virus particle release. In this study, we expressed the N protein of SARS-CoV-2 and characterized its biochemical properties. Static light scattering, size exclusive chromatography, and small-angle X-ray scattering (SAXS) showed that the purified N protein is largely a dimer in solution. CD spectra showed that it has a high percentage of disordered region at room temperature while it was best structured at 55 °C, suggesting its structural dynamics. Fluorescence polarization assay showed it has non-specific nucleic acid binding capability, which raised a concern in using it as a diagnostic marker. Immunoblot assays confirmed the presence of IgA, IgM and IgG antibodies against N antigen in COVID-19 infection patients' sera, proving the importance of this antigen in host immunity and diagnostics.
Keywords: Antigenicity; COVID-19; Nucleocapsid protein; SARS-CoV-2; SAXS; Structure and function.
Copyright © 2020. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.JCI Insight. 2020 Sep 17;5(18):e142386. doi: 10.1172/jci.insight.142386. JCI Insight. 2020. PMID: 32796155 Free PMC article.
-
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2271-2277. doi: 10.1007/s10096-020-03978-6. Epub 2020 Jul 17. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32681308 Free PMC article.
-
S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.mBio. 2020 Sep 25;11(5):e01991-20. doi: 10.1128/mBio.01991-20. mBio. 2020. PMID: 32978311 Free PMC article.
-
The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.Protein J. 2020 Jun;39(3):198-216. doi: 10.1007/s10930-020-09901-4. Protein J. 2020. PMID: 32447571 Free PMC article. Review.
-
COVID-19: molecular diagnostics overview.J Mol Med (Berl). 2020 Jul;98(7):947-954. doi: 10.1007/s00109-020-01931-w. Epub 2020 Jun 13. J Mol Med (Berl). 2020. PMID: 32535768 Free PMC article. Review.
Cited by
-
Natural products as a source of Coronavirus entry inhibitors.Front Cell Infect Microbiol. 2024 Feb 21;14:1353971. doi: 10.3389/fcimb.2024.1353971. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38449827 Free PMC article. Review.
-
Applications of Mass Spectrometry in the Characterization, Screening, Diagnosis, and Prognosis of COVID-19.Adv Exp Med Biol. 2024;1443:33-61. doi: 10.1007/978-3-031-50624-6_3. Adv Exp Med Biol. 2024. PMID: 38409415
-
Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity.Signal Transduct Target Ther. 2024 Feb 14;9(1):40. doi: 10.1038/s41392-024-01748-w. Signal Transduct Target Ther. 2024. PMID: 38355661 Free PMC article.
-
Antivirals for Broader Coverage against Human Coronaviruses.Viruses. 2024 Jan 20;16(1):156. doi: 10.3390/v16010156. Viruses. 2024. PMID: 38275966 Free PMC article. Review.
-
The role of nutritional support with probiotics in outpatients with symptomatic acute respiratory tract infections: a multicenter, randomized, double-blind, placebo-controlled dietary study.BMC Nutr. 2024 Jan 4;10(1):4. doi: 10.1186/s40795-023-00816-8. BMC Nutr. 2024. PMID: 38178223 Free PMC article.
References
-
- WHO Novel coronavirus – China. http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ accessed Jan 19, 2020.
-
- WHO Coronavirus (COVID-19) https://covid19.who.int/
-
- Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., Zhou H., Hu Z., Zhou W., Zhao L., Chen J., Meng Y., Wang J., Lin Y., Yuan J., Xie Z., Ma J., Liu W.J., Wang D., Xu W., Holmes E.C., Gao G.F., Wu G., Chen W., Shi W., Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England) 2020;395:565–574. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
